Vaughan Nelson Investment Management L.P. lowered its stake in shares of Envision Healthcare Co. (NYSE:EVHC) by 55.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,455,423 shares of the company’s stock after selling 1,804,956 shares during the period. Envision Healthcare comprises about 1.1% of Vaughan Nelson Investment Management L.P.’s investment portfolio, making the stock its 13th largest position. Vaughan Nelson Investment Management L.P. owned about 1.25% of Envision Healthcare worth $91,211,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of the stock. BlackRock Inc. raised its position in Envision Healthcare by 3,895.0% in the first quarter. BlackRock Inc. now owns 7,197,631 shares of the company’s stock valued at $441,359,000 after buying an additional 7,017,467 shares during the last quarter. Janus Capital Management LLC raised its position in Envision Healthcare by 63.7% in the first quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company’s stock valued at $167,536,000 after buying an additional 1,055,014 shares during the last quarter. Hexavest Inc. acquired a new position in Envision Healthcare during the first quarter valued at $41,197,000. Vanguard Group Inc. raised its position in Envision Healthcare by 4.0% in the first quarter. Vanguard Group Inc. now owns 11,266,818 shares of the company’s stock valued at $690,881,000 after buying an additional 433,593 shares during the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in Envision Healthcare during the first quarter valued at $24,833,000. Institutional investors and hedge funds own 64.75% of the company’s stock.
Envision Healthcare Co. (EVHC) traded up 0.23% during midday trading on Friday, hitting $52.89. 1,356,946 shares of the stock traded hands. The company has a 50-day moving average of $59.52 and a 200-day moving average of $61.20. The stock’s market cap is $6.19 billion. Envision Healthcare Co. has a 1-year low of $51.44 and a 1-year high of $74.75.
Envision Healthcare (NYSE:EVHC) last issued its quarterly earnings results on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.75 by $0.04. Envision Healthcare had a negative net margin of 7.35% and a positive return on equity of 5.35%. The firm had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.96 billion. During the same period in the prior year, the firm earned $0.34 EPS. The business’s revenue was up 156.7% on a year-over-year basis. On average, equities analysts expect that Envision Healthcare Co. will post $1.40 EPS for the current fiscal year.
WARNING: This piece was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.com-unik.info/2017/08/11/envision-healthcare-corporation-evhc-shares-sold-by-vaughan-nelson-investment-management-l-p-updated-updated-updated.html.
Several equities research analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Envision Healthcare from a “hold” rating to a “strong sell” rating in a research note on Monday, May 8th. Canaccord Genuity reaffirmed a “buy” rating and set a $86.00 price target on shares of Envision Healthcare in a research note on Tuesday, April 18th. Royal Bank Of Canada lifted their price target on shares of Envision Healthcare from $72.00 to $77.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 27th. BidaskClub raised shares of Envision Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Finally, Jefferies Group LLC set a $75.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Friday, April 21st. One analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Envision Healthcare has an average rating of “Buy” and an average price target of $71.56.
In other news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $62.69, for a total value of $94,035.00. Following the completion of the transaction, the insider now owns 97,863 shares in the company, valued at approximately $6,135,031.47. The sale was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 3.10% of the company’s stock.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
What are top analysts saying about Envision Healthcare Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Co. and related companies.